Haemophilus Haemolyticus: a Human Respiratory Tract Commensal to Be Distinguished from Haemophilus Influenzae
Overview
Affiliations
Background: Haemophilus influenzae is a common pathogen in adults with chronic obstructive pulmonary disease (COPD). In a prospective study, selected isolates of apparent H. influenzae had an altered phenotype. We tested the hypothesis that these variant strains were genetically different from typical H. influenzae.
Methods: A prospective study of adults with COPD was conducted. Strains of apparent H. influenzae obtained from a range of clinical sources were evaluated by ribosomal DNA sequence analysis, multilocus sequence analysis, DNA-DNA hybridization, and sequencing of the conserved P6 gene.
Results: Variant strains were determined to be Haemophilus haemolyticus by means of 4 independent methods. Analysis of 490 apparent H. influenzae strains, identified by standard methods, revealed that 39.5% of sputum isolates and 27.3% of nasopharyngeal isolates were H. haemolyticus. Isolates obtained from normally sterile sites were all H. influenzae. In a prospective study, acquisitions of new strains of H. haemolyticus were not associated with exacerbations of COPD, whereas 45% of acquisitions of new strains of H. influenzae were associated with exacerbations.
Conclusions: Standard methods do not reliably distinguish H. haemolyticus from H. influenzae. H. haemolyticus is a respiratory tract commensal. The recognition that some strains of apparent H. influenzae are H. haemolyticus substantially strengthens the association of true H. influenzae with clinical infection.
Hu J, Sethi S Expert Rev Respir Med. 2024; 18(9):693-707.
PMID: 39175157 PMC: 11583054. DOI: 10.1080/17476348.2024.2396413.
Update on bacterial pathogens: virulence and resistance.
Cercenado E, Garau J, Almirante B, Azanza J, Canton R, Cisterna R Enferm Infecc Microbiol Clin. 2024; 26:3-21.
PMID: 38620184 PMC: 7130156. DOI: 10.1016/S0213-005X(08)76378-X.
Fulte S, Atto B, McCarty A, Horn K, Redzic J, Eisenmesser E mSphere. 2024; 9(3):e0000624.
PMID: 38380941 PMC: 10964412. DOI: 10.1128/msphere.00006-24.
Tran X, Hoang V, Dao T, Marty P, Gautret P J Epidemiol Glob Health. 2024; 14(2):498-501.
PMID: 38372891 PMC: 11176107. DOI: 10.1007/s44197-024-00195-8.
Prevalence of piperacillin/tazobactam resistance in invasive in Germany.
Duske H, Claus H, Krone M, Lam T JAC Antimicrob Resist. 2024; 6(1):dlad148.
PMID: 38161964 PMC: 10753915. DOI: 10.1093/jacamr/dlad148.